ing. B.N. Hoogeboom

No picture available
E-mail:
b.n.hoogeboom umcg.nl

Research

Publications
  1. First-in-Human Phase I Clinical Trial of an SFV-Based RNA Replicon Cancer Vaccine against HPV-Induced Cancers

    Komdeur, F. L., Singh, A., van de Wall, S., Meulenberg, J. J. M., Boerma, A., Hoogeboom, B. N., Paijens, S. T., Oyarce, C., de Bruyn, M., Schuuring, E., Regts, J., Marra, R., Werner, N., Sluis, J., van der Zee, A. G. J., Wilschut, J. C., Allersma, D. P., van Zanten, C. J., Kosterink, J. G. W., Jorritsma-Smit, A., Yigit, R., Nijman, H. W. & Daemen, T., 2020, (Accepted/In press) In : Molecular Therapy.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Alphavirus-based hepatitis C virus therapeutic vaccines: can universal helper epitopes enhance HCV-specific cytotoxic T lymphocyte responses?

    Koutsoumpli, G., Ip, P. P., Schepel, I., Hoogeboom, B. N., Boerma, A. & Daemen, T., 3-Oct-2019, In : Therapeutic Advances in Vaccines and Immunotherapy. 7, p. 1-13 13 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. A rationally designed combined treatment with an alphavirus-based cancer vaccine, sunitinib and low-dose tumor irradiation completely blocks tumor development

    Draghiciu, O., Boerma, A., Hoogeboom, B. N., Nijman, H. W. & Daemen, T., 2015, In : OncoImmunology. 4, 10, 9 p., 1029699.

    Research output: Contribution to journalArticleAcademicpeer-review

  4. Tattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7

    van de Wall, S., Walczak, M., van Rooij, N., Hoogeboom, B-N., Meijerhof, T., Nijman, H. W. & Daemen, T., 24-Mar-2015, In : Vaccines. 3, 2, p. 221-238 18 p.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (16) »

ID: 218792